Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated analogs of bioactive molecules. Its structure allows for further functionalization in drug discovery processes, especially in creating compounds with enhanced metabolic stability and receptor binding affinity. Commonly employed in the preparation of selective enzyme inhibitors and central nervous system agents due to the presence of both bromo and fluoro substituents that influence electronic and steric properties. Also utilized in asymmetric synthesis to produce enantiomerically pure drugs.